Back to Search
Start Over
Retinoic acid receptor-related orphan receptor alpha and synthetic RORα agonist against invasion and metastasis in tongue squamous cell carcinoma.
- Source :
-
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Nov 12; Vol. 733, pp. 150421. Date of Electronic Publication: 2024 Jul 18. - Publication Year :
- 2024
-
Abstract
- Retinoic acid receptor-related orphan receptor alpha (RORα), an essential tumor suppressor in a range of human malignancies, is classified as a member of the orphan nuclear receptor family. The most prevalent form of oral cancer, tongue squamous cell carcinoma (TSCC) is characterized by its severe malignancy and unfavorable prognosis. However, the extent to which its tumorigenesis mechanisms are associated with RORα expression levels is still not fully understood. The objective of this study was to examine the molecular mechanisms by which RORα is involved in TSCC. Through the use of immunohistochemistry (IHC), it was discovered that the expression level of RORα was significantly downregulated in TSCC tissues when compared to adjacent normal tissues in this study. To further investigate the role of RORα in TSCC, we activated the expression of RORα in human TSCC cell line (SCC9 cells) by transfecting RORα cDNA and using the selective RORα agonist SR1078. The results show that RORα can significantly inhibit the invasion, migration, proliferation, and adhesion of TSCC cells and induce cell apoptosis. In addition, xenograft models confirmed the conclusion that stable activation or treatment with SR1078 to increase RORα content significantly inhibited tumor growth and development. Taken together, this study provides solid evidence for the inhibitory role of RORα in the progression of TSCC. In addition, the preliminary application results of SR1078 in TSCC show that SR1078 is expected to be a potential therapeutic medication for TSCC. These findings provide innovative perspectives on the development of potential biomarkers and agents for TSCC therapy. The objective is to introduce novel strategy and alternatives for the prevention and treatment of TSCC.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Subjects :
- Humans
Animals
Cell Line, Tumor
Cell Movement drug effects
Apoptosis drug effects
Cell Proliferation drug effects
Mice
Mice, Inbred BALB C
Xenograft Model Antitumor Assays
Neoplasm Metastasis
Antineoplastic Agents pharmacology
Female
Male
Gene Expression Regulation, Neoplastic drug effects
Benzamides
Fluorocarbons
Tongue Neoplasms pathology
Tongue Neoplasms metabolism
Tongue Neoplasms genetics
Tongue Neoplasms drug therapy
Nuclear Receptor Subfamily 1, Group F, Member 1 metabolism
Nuclear Receptor Subfamily 1, Group F, Member 1 genetics
Nuclear Receptor Subfamily 1, Group F, Member 1 agonists
Neoplasm Invasiveness
Carcinoma, Squamous Cell metabolism
Carcinoma, Squamous Cell pathology
Carcinoma, Squamous Cell genetics
Carcinoma, Squamous Cell drug therapy
Mice, Nude
Subjects
Details
- Language :
- English
- ISSN :
- 1090-2104
- Volume :
- 733
- Database :
- MEDLINE
- Journal :
- Biochemical and biophysical research communications
- Publication Type :
- Academic Journal
- Accession number :
- 39047426
- Full Text :
- https://doi.org/10.1016/j.bbrc.2024.150421